CompletedNot Applicable

Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use

5,234 participantsStarted 2007-01

Plain-language summary

The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Eligibility as determined by criteria for participation in studies as part of the MQIC * Agreement of participating clinical practices to undergo training in the electronic health record (EHR) intervention designed for this study Exclusion Criteria: * Based on voluntary participation by MQIC practices, so practices were excluded if they decided to opt out

What they're measuring

Diagnoses of GERD

Timeframe: After 12 months of intervention

Prescriptions for gastroprotective medicines in at-risk, chronic NSAID users

Timeframe: After 12 months of intervention

Trial details

NCT IDNCT00691171

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2008-06

View on ClinicalTrials.gov More GERD trials